Previous studies have found that PRLR plays an important role in pancreatic cancer [23], ovarian cancer [24], prostate cancer [25], Hodgkin’s lymphoma [26], prolactinoma [27], and BC [28]. Here, PRLR is linked to prostate carcinoma.